439 related articles for article (PubMed ID: 21500195)
1. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
2. HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.
De Re V; De Zorzi M; Caggiari L; Lauletta G; Tornesello ML; Fognani E; Miorin M; Racanelli V; Quartuccio L; Gragnani L; Russi S; Pavone F; Ghersetti M; Costa EG; Casarin P; Bomben R; Mazzaro C; Basaglia G; Berretta M; Vaccher E; Izzo F; Buonaguro FM; De Vita S; Zignego AL; De Paoli P; Dolcetti R
Oncotarget; 2016 Jun; 7(25):37487-37497. PubMed ID: 27183918
[TBL] [Abstract][Full Text] [Related]
3. Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients.
Neamatallah M; El-Bendary M; Elalfy H; Besheer T; El-Maksoud MA; Elhammady D; Abed S; Elegezy M; Kandeel L; Eldeib D; Mousa N; Abd El-Hafeez M; El-Gilany AH; Esmat G
Immunol Invest; 2020 May; 49(4):462-476. PubMed ID: 31615295
[No Abstract] [Full Text] [Related]
4. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients.
Sghaier I; Mouelhi L; Rabia NA; Alsaleh BR; Ghazoueni E; Almawi WY; Loueslati BY
Cytokine; 2017 Jan; 89():62-67. PubMed ID: 28340949
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma.
Agúndez JA; García-Martín E; Devesa MJ; Carballo M; Martínez C; Lee-Brunner A; Fernández C; Díaz-Rubio M; Ladero JM
Oncology; 2012; 82(1):35-40. PubMed ID: 22286521
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
Wang Y; Kato N; Hoshida Y; Yoshida H; Taniguchi H; Goto T; Moriyama M; Otsuka M; Shiina S; Shiratori Y; Ito Y; Omata M
Hepatology; 2003 Jan; 37(1):65-71. PubMed ID: 12500190
[TBL] [Abstract][Full Text] [Related]
9. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma.
Labib HA; Ahmed HS; Shalaby SM; Wahab EA; Hamed EF
Cell Immunol; 2015 Mar; 294(1):21-4. PubMed ID: 25666505
[TBL] [Abstract][Full Text] [Related]
13. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
ELBassuoni MA; Abd El Fatah G; Zaghla H
Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
[TBL] [Abstract][Full Text] [Related]
14. The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients.
Nischalke HD; Berger C; Luda C; Müller T; Berg T; Coenen M; Krämer B; Körner C; Trebicka J; Grünhage F; Lammert F; Nattermann J; Sauerbruch T; Spengler U
J Hepatol; 2012 Apr; 56(4):758-64. PubMed ID: 22173151
[TBL] [Abstract][Full Text] [Related]
15. The Correlation of Increased CRP Levels with NFKB1 and TLR2 Polymorphisms in the Case of Morbid Obesity.
Soydas T; Karaman O; Arkan H; Yenmis G; Ilhan MM; Tombulturk K; Tasan E; Kanigur Sultuybek G
Scand J Immunol; 2016 Nov; 84(5):278-283. PubMed ID: 27507606
[TBL] [Abstract][Full Text] [Related]
16. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
Elsayed HM; Nabiel Y; Sheta T
Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
18. Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infection.
Divella R; Mazzocca A; Gadaleta C; Simone G; Paradiso A; Quaranta M; Daniele A
Cancer Genomics Proteomics; 2012; 9(4):193-8. PubMed ID: 22798504
[TBL] [Abstract][Full Text] [Related]
19. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
[TBL] [Abstract][Full Text] [Related]
20.
Barooah P; Saikia S; Kalita MJ; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
Viral Immunol; 2020; 33(6):457-467. PubMed ID: 32352886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
